Featured Articles

Rapid Osteogenic Enhancement of Stem Cells in Human Bone Marrow Using a Glycogen‐Synthease‐Kinase‐3‐Beta Inhibitor Improves Osteogenic Efficacy In Vitro and In Vivo

Non-union defects of bone are a major problem in orthopedics, especially for patients with a low healing capacity. Autologous human bone marrow (hBM) is often used as a source for osteogenic stem cells, but efficacy is contingent on the healing capacity of the patients. Herein, this study shows that exposure of hBM to a glycogen-synthease-kinase inhibitor for a very short time, initiates an irreversible cascade that increases the osteogenic capacity of resident stem cells. Importantly, the BIO-treated hBM has the capacity to generate stronger and more compact fusion masses when tested in a rodent spine fusion model. This approach could represent a feasible and cost-effective strategy for functional enhancement of autologous hBM for orthopedic applications.

Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non‐Small Cell Lung Cancer: The Role of Cancer Stem Cells

Resistance to treatment in non-small cell lung cancer is one of the major obstacles for clinicians. Recently, mutations in different genes have emerged as potential biomarkers of acquired resistance to treatment, however, little is known about the role of cancer stem cells. The present Review addresses how cancer stem cells can contribute to treatment resistance and how it can be overcome.


Journal Club Discussions

February 5, 2018

A new study establishes that the injection of a collagen-based biomaterial can mobilize endogenous stem cells to promote kidney regeneration in a mouse model



Article Scans

February 17, 2018
A new STEM CELLS study describes how two members of the regeneration-associated Notch signaling pathway combine to coordinate muscle stem cell regulation
February 17, 2018
New research from the University of North Carolina establishes a link between rapid origin licensing and the maintenance of stem cell pluripotency
February 12, 2018
Researchers discover that an actin-cytoskeleton modifying fungal metabolite can promote the osteogenesis of adipose stem cells via an epigenetic mechanism